Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Acitretin therapy may cause hair to repigment and curl.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

DiluCap improves how quickly minoxidil and finasteride dissolve and controls the release of melatonin and naltrexone.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Butin is effective in treating vitiligo in mice.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Redenyl lotion effectively promotes hair growth and improves quality of life for androgenetic alopecia patients.

Biologics for severe asthma have known side effects, but some new risks need more study.

The drug was successfully released into hair follicles using nanocarriers.

Bortezomib chemotherapy can cause temporary skin rashes.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Finasteride's molecular properties and active sites were identified using computational methods.

17β-estradiol can reduce inflammation in the skin.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.